CompletedNot Applicable

Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography

Turkey (Türkiye)25 participantsStarted 2023-07-24

Plain-language summary

This study aims to evaluate the necessity and effectiveness of using low molecular weight heparin (LMWH) for prophylaxis in the postoperative period in patients who underwent lobectomy due to malignancy, using thromboelastography.Blood samples taken from the patients before low molecular weight heparin prophylaxis (preoperative), before prophylaxis in the postoperative period (postoperative day 1) and after the start of postoperative prophylaxis (postoperative day 3) will be examined by thromboelastography.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who underwent lobectomy with thoracotomy or videothoracoscopy (VATS) due to malignancy (primary or secondary lung cancer) Exclusion Criteria: * Patients with a known diagnosis of bleeding or coagulation disorders * Patients receiving anticoagulant and antiplatelet therapy in the preoperative period * Patients who developed perioperative bleeding and therefore underwent perioperative blood and blood product replacement

What they're measuring

r time

Timeframe: 24 months

k time

Timeframe: 24 months

maximum amplitude (MA)

Timeframe: 24 months

angle a

Timeframe: 24 months

Trial details

NCT IDNCT06484231

SponsorEge University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-06

View on ClinicalTrials.gov More Malignancy trials